NeuroTransit Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

NeuroTransit General Information

Description

Owner and operator of a bio pharmaceutical company intended to offer therapeutics for neurologic, metabolic and oncologic diseases. The company bio pharmaceutical services include using proprietary technology for the development of drug products that cross the blood-brain barrier, enabling patients to avail treatment for neurologic, metabolic and oncologic diseases of the brain.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Corporate Office
  • 6020 Cornerstone West Court
  • Suite 200
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroTransit Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Feb-2018 Completed Out of Business
1. Early Stage VC 01-Jan-2013 Completed Startup
To view NeuroTransit’s complete valuation and funding history, request access »

NeuroTransit Executive Team (2)

Name Title Board Seat Contact Info
Michael Dunn Co-Founder, President and Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

NeuroTransit FAQs

  • When was NeuroTransit founded?

    NeuroTransit was founded in 2008.

  • Who is the founder of NeuroTransit?

    Brian Spencer Ph.D and Michael Dunn are the founders of NeuroTransit.

  • Who is the CEO of NeuroTransit?

    Michael Dunn is the CEO of NeuroTransit.

  • Where is NeuroTransit headquartered?

    NeuroTransit is headquartered in San Diego, CA.

  • What industry is NeuroTransit in?

    NeuroTransit’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is NeuroTransit a private or public company?

    NeuroTransit is a Private company.

  • What is NeuroTransit’s current revenue?

    The current revenue for NeuroTransit is 000000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »